NovoCure Ltd — Director's Dealing 2018

May 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-05-15

Reporting Person: LEUNG GABRIEL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-15	Ordinary Shares	M	40000	$3.44	Acquired	40000	Direct
2018-05-15	Ordinary Shares	S	40000	$28.88	Disposed	0	Direct
2018-05-16	Ordinary Shares	M	100000	$3.44	Acquired	100000	Direct
2018-05-16	Ordinary Shares	S	40000	$28.77	Disposed	60000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-15	Options to Buy Ordinary Shares	$3.44	M	40000	Acquired	2021-09-15	Ordinary Shares (40000)	Direct
2018-05-16	Options to Buy Ordinary Shares	$3.44	M	100000	Acquired	2021-09-15	Ordinary Shares (100000)	Direct

Footnotes

F1: On May 15, 2018, Mr. Leung sold 40,000 shares in multiple trades at prices ranging from $28.80 to $28.98. The price reported above reflects the weighted average sale price. Mr. Leung hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2: On May 16, 2018, Mr. Leung sold 40,000 shares in multiple trades at prices ranging from $28.65 to $28.94. The price reported above reflects the weighted average sale price. Mr. Leung hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: Options to buy 40,000 ordinary shares are vested and currently exercisable as of the date hereof.

F4: Options to buy 100,000 ordinary shares are vested and currently exercisable as of the date hereof.